English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Robert Hadley
| Jun 18, 2017
Study may lead to development of Lassa vaccine
Robert Hadley
| Jun 16, 2017
Calithera says trials indicate new drug can inhibit growth of solid tumors
Robert Hadley
| Jun 16, 2017
Merck’s Keytruda shown effective in treating aggressive form of breast cancer
Cheyenne Dickerson
| Jun 16, 2017
Scientists hoping to better evaluate and treat kidney cancer with new laboratory models
Erianne Leatherman
| Jun 15, 2017
Novartis, IBM Watson join forces to fight breast cancer
Robert Hadley
| Jun 15, 2017
Computer modeling may lead to increase in detection of colorectal cancer
Ruth de Jauregui
| Jun 14, 2017
Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Ruth de Jauregui
| Jun 14, 2017
AbbVie says upadacitinib trial shows promising results for rheumatoid arthritis patients
Trending
+
Regulatory
C.D. Marsden
| Apr 12, 2025
Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'
« First
«
…
30
31
32
33
34
35
36
…
»
Last »